Skip to content

Evaluation of an Infant Feeding Intervention for HIV-exposed Haitian Infants

Evaluation of an Infant Feeding Support Strategy for HIV-exposed Infants 6-12 Months Old in Urban Haiti

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01434238
Enrollment
82
Registered
2011-09-14
Start date
2008-06-30
Completion date
2010-05-31
Last updated
2011-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lack of; Care, Infant (Child), Malnutrition

Keywords

infant feeding, HIV, growth, anemia

Brief summary

The purpose of this quasi-experimental study is to evaluate the effectiveness of an infant feeding intervention in improving growth and anemia outcomes among HIV-exposed infants 6-12 months of age.

Detailed description

The need for better nutrition during infancy to improve growth and child survival outcomes is well recognized and is especially acute in the context of maternal human immunodeficiency virus (HIV) infection. WHO Guidelines on Infant Feeding and HIV call for support of HIV-infected caregivers during infant feeding transitions across the first year of life. However, there are few published examples of programmatic approaches that effectively integrate PMTCT and infant feeding support at the service delivery level. The objectives of this study are to develop and test an infant feeding support intervention among non-breastfed HIV-exposed infants age 6-12 months enrolled in the Prevention of Mother-to-Child Transmission of HIV program at the GHESKIO centres, an HIV and TB treatment clinic in urban Port-au-Prince, Haiti. The investigators hypothesize that growth and anemia outcomes will be better in the intervention cohort compared to historical controls. The investigators also hypothesize that the infant feeding support intervention will be feasible and acceptable to mothers and clinical staff. To accomplish these objectives, the investigators will enroll 82 HIV-exposed infants age 5.5-6.5 months recruited from the GHESKIO pediatric clinic in a 24-week intervention that includes a) a daily ration of fortified lipid-based nutrient supplement and b) nutrition counseling delivered through biweekly group and individualized sessions. Data on growth, supplement use, infant feeding knowledge and practices will be collected every 4 weeks during the intervention period. Hemoglobin and dietary intake will be assessed at baseline, mid-point and end of intervention. Intervention children will be seen 6-months post intervention to assess growth and anemia outcomes. Growth and anemia outcomes in the intervention group will be compared to medical record data from same-age HIV-exposed children seen at GHESKIO in the previous year.

Interventions

OTHERCounseling and nutrition supplement

24-week intervention that includes a) a daily ration of fortified lipid-based nutrient supplement and b) nutrition counseling delivered through biweekly group and individualized sessions. Dietary supplement is a locally- produced lipid-based nutrient spread (Meds and Foods for Kid, Cap Haitian, Haiti) that in a 65g daily ration provides 345 kcal energy and single allowance of key micronutrients for the 6-12 month age group.

Sponsors

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
CollaboratorOTHER
Weill Medical College of Cornell University
CollaboratorOTHER
University of Virginia
CollaboratorOTHER
Cornell University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 18 Months
Healthy volunteers
Yes

Inclusion criteria

* Confirmed maternal HIV-infection * Age 5.5-6.5 months at intervention start * Weight-for-length z-score \> -3 SD (WHO 2006 reference)

Exclusion criteria

* Confirmed or suspected allergy to peanuts * Participation in a concurrent clinical trial at GHESKIO

Design outcomes

Primary

MeasureTime frameDescription
Change in prevalence of growth faltering during the interventionend of intervention (approximately 12 months of age)Change in weight-for-age, length-for-age and weight-for-length \<-2 SD based on WHO 2006 Growth Standard
Change in prevalence of growth faltering post-interventionSix-months post-intervention (approximately 18 months of age)Change in weight-for-age, length-for-age and weight-for-length \<-2 SD based on WHO 2006 Growth Standard

Secondary

MeasureTime frameDescription
Change in prevalence of anemia during interventionend of intervention (approximately 12 months of age)Prevalence of anemia (Hb \< 10.5 g/dl)
Dietary intakeend of intervention (approximately 12 months of age)dietary nutrient intakes assessed through 24-hour dietary recall

Countries

Haiti

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026